32 Biosciences

32 Biosciences

Pre-clinical
San Francisco, United StatesFounded 201832biosciences.com

Pioneering gut mucosal-immune science to prevent and treat gastrointestinal diseases Learn More Pioneering gut mucosal-immune science to prevent and treat gastrointestinal diseases Learn More Our Solutions GI Discovery Platform Measures metabolomic signatures of the gut mucosal-immune system to enable therapeutic discovery, development, and clinical decision support. 3 Leading Use Cases CS Therapeutic Platform Mucosal Immune […]

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Funding information not available

About

Pioneering gut mucosal-immune science to prevent and treat gastrointestinal diseases Learn More Pioneering gut mucosal-immune science to prevent and treat gastrointestinal diseases Learn More Our Solutions GI Discovery Platform Measures metabolomic signatures of the gut mucosal-immune system to enable therapeutic discovery, development, and clinical decision support. 3 Leading Use Cases CS Therapeutic Platform Mucosal Immune […]

DiagnosticsMicrobiome

Funding History

1
SeedUndisclosedJun 15, 2023